In addition, patients with retinoma, a benign, non-progressive retinal lesion, who carry germline RB1 mutations (H1) with no full-blown retinoblastoma, still carry a risk for second non-ocular malignancies. This evidence concerns the gene RB1 and retinoblastoma.